medroxyprogesterone acetate has been researched along with Wasting Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antonietti, C; Gilli, G; Lelli, G; Montanari, M; Scapoli, D | 1 |
| Ghiani, M; Lai, P; Macciò, A; Mantovani, G; Massa, E; Santona, MC | 1 |
2 review(s) available for medroxyprogesterone acetate and Wasting Disease
| Article | Year |
|---|---|
Treatment of the cancer anorexia-cachexia syndrome: a critical reappraisal.
Topics: Anorexia; Cachexia; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Medroxyprogesterone Acetate; Megestrol Acetate; Metoclopramide; Neoplasms; Prognosis; Risk Assessment; Severity of Illness Index; Survival Analysis; Terminally Ill; Treatment Outcome; Wasting Syndrome | 2003 |
Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate.
Topics: Anorexia; Appetite Stimulants; Cachexia; Cytokines; Humans; Interleukin-1; Interleukin-6; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasms; Progesterone Congeners; Tumor Necrosis Factor-alpha; Wasting Syndrome | 1998 |